World News Insights
1-3 Minute Gist

All Topics Article

Vioxx Settlement Plan Heads for Key Deadlines

Wall Street Journal Original article ›

Keywords:

LyrArc Article Gist
Remaining challenges Merck faces to wrap up the Vioxx settlement .The main fear is that enough plaintiffs opt out of the settlement that it ends up costing Merck substantially more than anticipated like the Wyeth settlement that ended up costing Wyeth $21 billion fo afen-phen diet drug litigation because enough plaintiffs opted out. Tho prevent this Merck has include language in it agreeemtn that requires plaintiff lawyers to recommend settlement to those holding out and requires them to drop representing them.


Support LyrArc

We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.

Support Lyrarc from as small as $1


Copyright © 2006 - 2026 Intelilinks LLC
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us